Management Team of Amarillo Biosciences, Inc., Discuss Upcoming Studies and Successful Passing of FDA's 30-day Review (Business Wire via Yahoo! Finance)
AUSTIN, Texas----Aug. 17, 2006--SmallCapVoice.com, Inc. today announced that a new audio interview is available at SmallCapVoice.com. The featured guests are Joseph and Marty Cummins of Amarillo Biosciences .

NMT Medical Voluntarily Withdraws CardioSEAL(R) PFO HDE And Receives FDA Approval For New STARFlex(R) PFO IDE Study (Medical News Today)
NMT Medical, Inc. (Nasdaq:NMTI), an advanced medical technology company that designs, develops,manufactures and markets proprietary implant technologies that allowinterventional cardiologists to treat cardiac sources of migraineheadaches, stroke and other potential brain attacks, announced today thatit has voluntarily withdrawn the Humanitarian Device Exemption (HDE)granted by the U. [click link